Genomtec S.A. (WSE:GMT)

Market Cap	97.80M
Revenue (ttm)	1,000.00
Net Income (ttm)	-11.58M
Shares Out	13.32M
EPS (ttm)	-0.87
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	62,092
Average Volume	44,364
Open	7.55
Previous Close	7.35
Day's Range	7.35 - 7.59
52-Week Range	6.50 - 14.40
Beta	0.24
RSI	48.12
Earnings Date	Feb 11, 2025

About Genomtec

Genomtec S.A. researches, develops, manufactures, and commercializes innovative molecular diagnostic products in optical systems and isothermal nucleic acid amplification methods in Poland and internationally. The company develops Genomtec ID, a technological device that offer mobile genetic diagnosis to patients through streamlined nucleic acid amplification technology (SNAAT) to detect viruses, bacteria, and fungi, as well as genetic mutations by analyzing the biological material of patients using swabs, urine samples, saliva, blood, and othe...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2016
• Employees: 17
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: GMT

Financial Performance

In 2023, Genomtec's revenue was 1,000, a decrease of -97.50% compared to the previous year's 40,000. Losses were -9.01 million, -24.44% less than in 2022.